NeoGenomics rises after winning patent infringement lawsuit against Natera

NeoGenomics

29/08/2025 16:41

Updates

** Shares of biotech co NeoGenomics NEO.O rise 22.9% to $8.87

** Co wins summary judgment in patent infringement lawsuit against Natera NTRA.O

** Co says the court stated that it will dismiss Natera's claims against NeoGenomics

     ** The court order means that NEO remains free to sell its early breast cancer screening test called RaDaR ST assay - co

** The diagnostic device is a sequencing test for the detection of minimal residual disease (MRD) and recurrence of breast cancer

** Including session moves, NEO down 46.7% YTD

 (Reporting by Sneha S K)

 ((Sneha.SK@thomsonreuters.com;))